3BIGS, a Korean company specializing in medical big data, said on Thursday that it has developed an early version of 3X-GPT which is specialized in mining biomedical data using OpenAI’s interface, ChatGPT.

ChatGPT is a natural language processing AI-based chatbot developed by OpenAI which has been drawing attention from various industries as its applications are very diverse.

3BIGS has collected more than 30 million scientific literature studies from PubMed of the National Center for Biotechnology Information (NCBI) to link genes, diseases, drugs, and clinical trial information on its text mining platform, 3X-TMiner.

Accordingly, 3X-GPT is being developed to help researchers quickly identify research trends, related drugs, diseases, and genetic variations by merging ChatGPT with its existing 3X-TMiner platform.

By developing a multi-omics platform that can analyze specialized biodata and genomes, transcripts, and proteins, 3BIGS is also conducting joint research with various domestic research institutes, hospitals, and pharmaceutical and medical aesthetic companies.

Due to a lack of IT experts in the bioindustry, 3BIGS has quickly launched a platform specialized in biodata called 3X-GPT at home and abroad to solve the issue of IT by establishing data centers in Hyderabad and Bangalore, India, said a 3BIGS official.

Domestically, the government recently announced investments in medical big data stating that it will focus on growing the health industry into a key strategic industry by promoting the “My Data in Medicine” platform and creating at least two new blockbuster drugs with annual sales of more than 1 trillion won ($757.6 billion) within the next five years.

"The data market is currently leading industries around the world, but the most diverse, complex, and important biodata is not properly used for business," 3BIGS CEO said Park Jun-hyung. "In order to compete globally, 3BIGS is promoting various businesses by first developing a platform customized with biodata to become a leading company in the bioindustry.”